Navigation Links
Kaiser Permanente study shows link between caffeine and miscarriage
Date:1/20/2008

January 21, 2008 (Oakland, Calif.) High doses of daily caffeine during pregnancy whether from coffee, tea, caffeinated soda or hot chocolate -- cause an increased risk of miscarriage, according a new study by the Kaiser Permanente Division of Research. The study controlled, for the first time, pregnancy-related symptoms of nausea, vomiting and caffeine aversion that tended to interfere with the determination of caffeines true effect on miscarriage risk. The research appears in the current online issue of American Journal of Obstetrics and Gynecology.

While previous research showed a link between caffeine consumption and miscarriage, this is the first study to thoroughly control for morning sickness, which typically causes many women to avoid caffeine, explained De-Kun Li, MD, Ph.D., an investigator with the Kaiser Permanente Division of Research and lead investigator of the study. This study strengthens the association between caffeine and miscarriage risk because it removes speculation that the association was due to reduced caffeine intake by healthy pregnant women, Li said.

To address that speculation, the study, which looked at 1,063 pregnant Kaiser Permanente members in San Francisco from October 1996 through October 1998, examined the caffeine effect among women who never changed their pattern of caffeine consumption during their pregnancy. Kaiser Permanente is the nations largest health plan with 8.7 million members, 416 medical offices and 32 hospitals in nine states and the District of Columbia.

Women who consumed 200 mg or more of caffeine per day (two or more cups of regular coffee or five 12-ounce cans of caffeinated soda) had twice the miscarriage risk as women who consumed no caffeine, said Li. Women who consumed less than 200 mg of caffeine daily had more than 40 percent increased risk of miscarriage.

The increased risk of miscarriage appeared to be due to the caffeine itself, rather than other possible c
'/>"/>

Contact: Danielle Cass
Danielle.X.Cass@kp.org
510-267-5354
Edelman Public Relations
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Kaiser Permanente Provides $1.4 Million in Holiday Gifts to 40 Metro Atlanta Nonprofits
2. Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
3. GDS / Denex Dental Selected by Kaiser Permanente Northwest
4. Kaiser Permanente and Discovery Health Team Up to Fight Childhood Obesity Epidemic
5. Kaiser Permanente Opens 15th Medical Facility in Georgia
6. Kaiser Permanente/Harvard Medical School study links lack of sleep to weight gain for new moms
7. Kaiser Permanente Recognized by NCQA for Innovative Program to Reduce Health Care Disparities
8. U.S. News & World Report Names Kaiser Permanente Top-Ranked Health Plan in Georgia
9. Kaiser Foundation Health Plan Earnings Support Investments in Member and Community Health
10. Kaiser Permanente Puts Personal Health Record Front and Center
11. Following Heart Disease Guidelines Saves Lives, According to a Kaiser Permanente Abstract Presented at AHA Scientific Sessions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)...ter suffering from women,s hair loss for almost te...d she,s sharing her progress and the secret behind... the release of her video diaries which include a ...r treatment. , (PRWeb UK)...er Zsanett Siklosi has released the video diaries ...
(Date:11/23/2009)...RNewswire-FirstCall/--InfoLogix,Inc.(Nasdaq: IFLG ...lutionsforthehealthcareandcommercialindustries,ann...ServicesatSiemensHealthServices,hasjoinedInfoLogix..., (Logo: http://www.newscom.com/cgi-bin/prnh/20090...HealthcareServicesforInfoLogix,Mr.Waywillberespons...
(Date:11/23/2009)...atients and survivors treated with chemotherapy su... chronic conditions, hindering patients, ability t...iversity of Rochester Medical Center. , A study ...ep troubles at nearly three times the rate of the ... in younger patients and those with lung and breas...
(Date:11/23/2009)...rop by 63 percent with moderate-to-high intensity ...News) -- Moderate-to-high intensity exercise such ...oke risk in older men but not in women, researcher... and women, average age 69, in Manhattan who were ...here were 238 strokes among the participants. At t...
Breaking Medicine News(10 mins):Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2
...ts have provided new details about how proteins us...Alzheimer's disease. Gunnar K. Gouras, as... Weill Medical College of Cornell University, New ... for a vaccine against the disease. "Antib...
...alf the central government funds allocated to figh...n southern states that, ironically, were strugglin...ected at least 1.4 million people across the count... help them contain the chikungunya fever. But a su...
...ll establish 30 world-class universities across th...country's entry into the knowledge economy, Prime... "This expansion is going to be a landmark in ...mong the top institutions in the world," the prime...
...must provide more flexible working, the BMA says t... that female doctors embarking on NHS careers outn...t of 435 doctors who graduated from UK medical sch...ed a similar study of medical graduates. This is i...
... with radiation retinopathy who were destined to g... longer through localized treatment with Avastin ,... study published in the June, 2007 Archives of Oph...thy, said Paul T. Finger, MD, lead author of the s...
...iction worldwide appears to be slowing down for al...s Office on Drugs and Crime said on Friday. "...uth of Afghanistan, a cancer that threatens secur.... "Furthermore, progress made in some countrie...
Other Medicine News:Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 2Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 3Health News:Chikungunya Spreads as Funds Remain Unspent 2Health News:India to Have 30 World-class Universities Across the Country: PM 2Health News:BMA Calls for Flexible Working as Number of Women Doctors Swell 2Health News:Untreatable Eye Disease Improves With Avastin 2Health News:Drug Addiction Slowing Down: UN Report 2
(Date:11/23/2009)...3/PRNewswire/--TwooftheChicagoarea,sleadingBoardCe...inwomen,sbreastimaging,couplingthelatesttechnology...soundwiththeabilitytohavethefullrangeofdigitalimag...foresheleavestheoffice.Drs.AhmedFaragandJoanWerber...hecurrent6-9monthwaitforanappointmentcommonlyfound...
(Date:11/23/2009)...23/PRNewswire-FirstCall/--NuVasive, Inc. (Nasdaq: ...ductsforminimallydisruptivesurgicaltreatmentsforth...hiefExecutiveOfficer,andMichaelJ.Lambert,Executive...topresentatthe21stAnnualPiperJaffrayHealthCareConf...day,December2,2009,at10:00a.m.ET.Mr.LukianovandMr....
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--Immucor,Inc.(Nasdaq:...t-reagentsystemstothebloodtransfusionindustry,toda...fray21stAnnualHealthCareConferenceinNewYork,NYwill...Company,spresentationisscheduledforTuesday,Decembe...tionwillbeavailablethroughthe"AboutUs--InvestorInf...
Breaking Medicine Technology:NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 2NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 32009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60 25 Despite Current Recession 12440 12009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60 25 Despite Current Recession 12440 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 1Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 3Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 4Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 5Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 6Global Decompression Announces C O D Available on All Used Axiom DRX 9000 Spinal Decompression Systems 47748 1Global Decompression Announces C O D Available on All Used Axiom DRX 9000 Spinal Decompression Systems 47748 2
... Program for Oral Compounds,to Treat Alcohol Depe...2, 2007--Alkermes, Inc.,(Nasdaq: ALKS) today annou...trial of ALKS 29 in alcohol dependent patients. Ba...rward with its,development program for oral produc...is a combination of two agents with distinct,pharm...
...07 -- DOR BioPharma, Inc.,(OTCBB: DORB) ("DOR" or ...lts from testing of a multivalent form of its botu...lished in the journal,Infection and Immunity (Ravi...75, p. 3043 ). These results are the first that,de...valent vaccine,that is active by the mucosal route...
Other Medicine Technology:Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 3Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 6
Chemstrip Micral
QED A350 Saliva Alcohol Test
AccuSign DOA Series Tests
...highly accurate in detecting the presence of drugs... GC/MS testing. This assay provides a preliminary ...uch as GC/MS) must be used in order to obtain a co...plied to any drug of abuse test result, particular...
Medicine Products: